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Summary A 45-year-old man with dilated cardiomyopathy was admitted to our hospital due
to congestive heart failure (CHF). Despite the optimal medical treatment, his condition had not
improved because of severe left ventricular dysfunction. Because he experienced non-sustained
ventricular tachycardia (VT), a biventricular implantable cardioverter-deﬁbrillator (Bi-V ICD)
was implanted for reduction of dyssynchrony and primary prevention of lethal tachyarrhythmia.
After discharge, he developed CHF and was transported to our hospital by ambulance. In the
ambulance, monomorphic sustained VT with 200 bpm suddenly occurred. The ICD detected it as
fast VT and anti-tachycardia pacing (ATP) was delivered. After the ATP therapy, RR intervals of
VT became irregular and prolonged. Ventricular ﬁbrillation-like electrical activity was recorded
by a far-ﬁeld electrogram from the deﬁbrillator, but the tachycardia cycle length exceeded
400ms which is under the tachycardia detection rate. The device failed to deliver a shock
rescuand the patient had to be
degenerated into undetectable
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Table 1 Implantable cardioverter-deﬁbrillator parameters.
Pacing threshold at implantation
(3 months follow-up)
Sensing threshold at
implantation (3 months
follow-up)
Lead impedance at
implantation (3 months
follow-up)
Atrial lead 0.8 V/0.5ms (0.8 V/0.5ms) 4.1mV (2.0mV) 529 (506)
RV lead 0.8 V/0.5ms (1.0 V/0.5ms) 10.8mV (7.0mV) 763 (767)
LV lead 1.2 V/0.5ms (1.2 V/0.5ms) 7.9mV (6.5mV) 876 (907)
Detection Threshold Detect beats Duration Therapies
VF 220 bpm 8 of 10 1 s 41J× 6
FVT (via VF) 180 bpm 8 of 10 2.5 s ATP (1 sequence), 41J× 5
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iVT 150 bpm 8 of 10
RV, right ventricular; LV, left ventricular; VF, ventricular ﬁbrillatio
anti-tachycardia pacing.
revention. An ICD can terminate ventricular tachyarrhyth-
ia by cardioversion or anti-tachycardia pacing (ATP).
owever, some patients who suffer from frequent discharges
f the ICD experience anxiety and depression [1]. Several
tudies have shown a correlation between poor quality of
ife (QoL) and frequent ICD shocks [2,3]. Recent studies
ave shown that empirical ATP for fast ventricular tachy-
ardia (FVT) is an effective, painless therapy and improves
oL [4,5]. Moreover, subsequent shocks can terminate tach-
arrhythmia even though ATP fails to terminate it. However,
e experienced a patient with dilated cardiomyopathy
DCM) in whom ATP degenerated FVT into life-threatening
olymorphic VT that could not be detected by an ICD.
ase report
45-year-old man with DCM was admitted to our hospi-
al due to congestive heart failure (CHF) in April 2008. He
xperienced severe dyspnea with minor exertion [New York
eart Association (NYHA) functional class III]. Echocardio-
raphy showed that the left ventricular ejection fraction
LVEF) was 10%. He experienced non-sustained VT but did
ot have sustained lethal arrhythmia. A biventricular (Bi-
) ICD was implanted for reduction of dyssynchrony and
rimary prevention of lethal tachyarrhythmia [ICD gener-
tor: Contak Renewal 4 HE (Boston Scientiﬁc Corp, St Paul,
N, USA), atrial lead: Capsure Fix Novus 5076-52 (Medtronic
nc, Minneapolis, MN, USA), right ventricular lead: Linox
D 65/18 (Biotronik GmbH, Berlin, Germany), left ventric-
lar lead: Easytrak2 4543 (Boston Scientiﬁc Corp)]. The ICD
as programmed with three tachycardia zones (Table 1).
VT therapy consisted of initial ATP [8 autodecremental
ulses at 88% cycle length (CL)] and subsequent shocks. The
ensing level was set nominal (≥0.27mV) at the time of
evice implantation (pass ﬁlter: 20Hz). ICD shock of 21 J
ould terminate induced ventricular ﬁbrillation (VF) during
deﬁbrillation threshold (DFT) test. Unfortunately, because
i-V pacing was not effective for CHF, the patient was placed
n the waiting list for a heart transplant in Japan. After
ischarge, he developed CHF and was transported to our
ospital by ambulance in October 2008. His metabolic sta-
us at the time of transportation did not include hyper-
r hypo-potassemia, or hypo-magnesemia, but slight renal
r
t
f
i
ﬁ2.5 s ATP (3 sequences), 41J× 3
T, fast ventricular tachycardia; VT, ventricular tachycardia; ATP,
ysfunction. He had taken diuretics, beta-blockers, and
ngiotensin II type 1 receptor blockers, but not amiodarone,
ecause of lung side effects. In the ambulance, monomor-
hic sustained VT with 200 beats per minute (bpm) suddenly
ccurred (Fig. 1). The ICD detected it as FVT and an ATP
as delivered. After the ATP therapy, the RR intervals of VT
ecame irregular and prolonged. VF-like electrical activity
as recorded by a far-ﬁeld electrogram, which was recorded
y bipolar between the ICD generator and deﬁbrillation
oil, and mimics a body surface electrocardiogram in the
imb lead. Although each RR interval of the tachyarrhyth-
ia encountered a VF zone, FVT zone, or slow VT zone,
he ICD could not deliver shock because the CL of the tach-
arrhythmia did not satisfy any of the criteria of VF zone
nd FVT zone. Finally, the tachycardia met slow VT criteria,
nd the ICD delivered a second ATP. The second ATP did not
erminate the tachycardia but prolonged CL and it became
ver 400ms (Fig. 1). The patient collapsed and resuscita-
ion was started. ICD shock was not delivered because the
L was out of range of ICD detection. Because the electro-
ardiogram of cardiac monitoring in the ambulance showed
VF waveform, we attempted deﬁbrillation of 360 J from an
xternal deﬁbrillator and the tachycardia was successfully
erminated (Fig. 2).
iscussion
TP for FVT sometimes induces VF which has short CL, and
ubsequent ICD shock terminates VF. Occasionally, ATP for
VT also induces slow VT with long CL, in which patients
sually do not collapse. However, in the present case, ATP
or FVT initiated slow but life-threatening VF-like elec-
rical activity that could not be detected by an ICD and
esulted in deteriorated hemodynamics. Whether this life-
hreatening arrhythmia was slow polymorphic VT or VF
ould be a key point in this case. ATP could introduce mul-
iple block and zones of slow conduction in the severely
njured myocardium. Multiple block and slow conduction
esulted in random reentry, and then ‘‘monomorphic sus-
ained VT’’ would convert to ‘‘slow polymorphic VT’’. In
act, after the ATP therapy, RR intervals of VT became
rregular and prolonged over 400ms (<150 bpm) in a near-
eld electrocardiogram and we therefore concluded that
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Figure 1 Monomorphic sustained ventricular tachycardia (VT) with a cycle length (CL) of 300ms occurred. The implantable
cardioverter-deﬁbrillator (ICD) detected it as fast VT and anti-tachycardia pacing (ATP) was delivered. After the ATP therapy, the
RR intervals of VT became irregular and prolonged. Ventricular ﬁbrillation (VF)-like electrical activity was recorded by a far-ﬁeld
electrogram. Each RR interval encountered a VF zone, fast VT zone or slow VT zone. The tachycardia met slow VT criteria, and
second ATP was delivered. After the second ATP therapy, the CL became over 400ms, which was out of the range of ICD detection
and ICD shock was not delivered. A: atrial electrogram; V: ventricular electrogram; near-ﬁeld, bipolar electrocardiogram of tip of
the deﬁbrillation lead; far-ﬁeld, bipolar electrocardiogram between the ICD generator and deﬁbrillation coil.
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[Figure 2 Electrogram of cardiac monitoring in the ambulan
of 360 J from an external deﬁbrillator was attempted and t
deﬁbrillation.
this arrhythmia was ‘‘slow polymorphic VT’’ because the
rate of VF is usually between 150 and 500 bpm. However,
in a far-ﬁeld electrogram of an ICD or ambulatory monitor-
ing, this arrhythmia seemed to be VF-like electrical activity
due to multiple block. This is a rare case with severe car-
diac dysfunction in which ATP could have been lethal to the
patient.
The PainFREE RXII and EMPIRIC trials have demonstrated
that empirical ATP for FVT is as useful as ICD shocks in
primary and secondary prevention for patients without indi-
cation for a Bi-V ICD [4,5]. More recently, the ADVANCE CRT-D
trial demonstrated that ATP is safe and effective for heart
failure patients with Bi-V ICDs [6]. When compared with
these trials, the efﬁcacy of ATP to terminate VTs was less
effective in patients with Bi-V ICD than in patients with-
out indication for a Bi-V ICD. In fact, the PainFREE RXII
trial demonstrated that deteriorated LVEF reduced success-
ful termination of VTs by ATP [4]. Our patient had low cardiac
function and it would have been associated with unsuccess-
ful ATP for FVT. In addition to low cardiac function, it has
been reported that the deﬁbrillation efﬁcacy in VT/VF is
signiﬁcantly dependent on the VT/VF duration and that a
long duration of VT/VF (>15 s) increased DFT [7]. Empiri-
cal ATP for FVT has an advantage in most patients with an
[howed a ventricular ﬁbrillation (VF) waveform. Deﬁbrillation
chycardia was successfully terminated by the ﬁrst external
CD; however, ATP for FVT is sometimes harmful for patients
ho have low LVEF, high NYHA functional class, and frequent
ecurrence of CHF, and early shock therapy is recommended
o avoid the succeeding unstable hemodynamics.
In conclusion, this is a rare case of FVT that
egenerated into undetectable life-threatening ventricular
achyarrhythmia by ATP. This case showed us practical impli-
ations relating to the programming of contemporary ICD
evices.
eferences
1] Heller SS, Ormont MA, Lidagoster L, Sciacca RR, Steinberg S.
Psychosocial outcome after ICD implantation: a current perspec-
tive. Pacing Clin Electrophysiol 1998;21:1207—15.
2] Schron EB, Exner D, Yao Q, Jenkins LS, Steinberg JS, Cook JR,
Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J. Quality
of life in the antiarrhythmics versus implantable deﬁbrillators
trial: impact of therapy and inﬂuence of adverse symptoms and
deﬁbrillator shocks. Circulation 2002;105:589—94.
3] Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK.
Quality-of-life six months after CABG surgery in patients ran-
domized to ICD versus no ICD therapy: ﬁndings from the CABG
Patch Trial. Pacing Clin Electrophysiol 1999;22:1305—13.
e[
[
[162
4] Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF,
Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein
DS, Volosin KJ, for the Pain FREE RxII Investigators. Prospective
randomized multicenter trial of empirical antitachycardia pac-
ing versus shocks for spontaneous rapid ventricular tachycardia
in patients with implantable cardioverter-deﬁbrillators: pacing
fast ventricular tachycardia reduces shock therapies (Pain FREE
RxII) trial results. Circulation 2004;110:2591—6.
5] Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD,
Morgan JM, for the EMPIRIC Trial Investigators. A comparison
of empiric to physician-tailored programming of implantable
cardioverter-deﬁbrillators: results from the prospective ran-
[K. Yunoki et al.
domized multicenter EMPIRIC trial. J Am Coll Cardiol
2006;48:330—9.
6] Gasparini M, Anselme F, Clémenty J, Santini M, Martinez-Ferrer
J, Mainardi M, De Santo T, Ligorio G, Schwab JO. Biventricu-
lar versus right ventricular delivered anti-tachycardia pacing for
the termination of ventricular tachyarrhythmias in heart failure
patients receiving a biventricular ICD: Results from the ADVANCE
CRT-D trial. Circulation 2008;118:S 1024.
7] Gradaus R, Bode-Schnurbus L, Weber M, Rötker J, Hammel D,
Breithardt G, Böcker D. Effect of ventricular ﬁbrillation duration
on the deﬁbrillation threshold in humans. Pacing Clin Electro-
physiol 2002;25:14—9.
